GC
GANX icon

Greenlight Capital’s Gain Therapeutics GANX Stock Holding History

Greenlight Capital’s Portfolio GANX Stock Details GANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.92M Hold
588,410
– – 0.09% 33
2023
Q3 		$1.93M Buy
588,410
+41,850
+8% +$159K 0.11% 30
2023
Q2 		$2.45M Hold
546,560
– – 0.11% 30
2023
Q1 		$2.63M Hold
546,560
– – 0.14% 29
2022
Q4 		$1.71M Hold
546,560
– – 0.12% 31
2022
Q3 		$1.78M Hold
546,560
– – 0.13% 31
2022
Q2 		$1.97M Hold
546,560
– – 0.15% 35
2022
Q1 		$2.24M Hold
546,560
– – 0.14% 39
2021
Q4 		$2.97M Hold
546,560
– – 0.18% 40
2021
Q3 		$4.07M Hold
546,560
– – 0.27% 32
2021
Q2 		$5.47M Hold
546,560
– – 0.34% 34
2021
Q1 		$8.15M Buy
+546,560
New +$7.17M 0.57% 28

Other funds holding GANX

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return